Resources - Events & Other Meetings

*18th ISoP Annual Meeting

11-14 November 2018, Geneva (Switzerland)
“Pharmacovigilance without borders”
The ISoP 2018 conference will run for three full days and include some exciting new ideas, keynote lectures, parallel sessions and symposia – including:
Two pre-conference courses “Pharmacovigilance in the aging population” and “Pharmacovigilance in pre-approval phases” on Sunday 11th November
⋆ WHO-ISoP joint session on WHO Coalition of Interested Partners (CIP)
⋆ CIOMS lecture “New use of Clinical Concepts in MedDRA: Can MedDRA Labelling Groupings help to standardise Safety Labelling?”
⋆ Keynote lectures and expert panel “Putting Patients First in Pharmacovigilance”
⋆ Four parallel sessions including i) Risk communication ii) Role of the pharmaceutical industry in pharmacovigilance iii) Medical devices iv) Benefit-Risk assessment
⋆ Twelve symposia organised by ISoP members, covering a range of key topics in pharmacovigilance
⋆ Plenary lecture “Artificial intelligence in pharmacovigilance and machine learning”
⋆ Poster presentations selected from over 380 abstracts submitted.
For further information and registration, please visit the conference website here

* NASoP Annual Meeting

November 2nd, 2018 – Roundtable: Structured Benefit-Risk Assessment Across the Therapeutic Product Lifecycle
Organized by the ISoP North America Chapter (NASoP)
Moderators: Veronique Kugener, SVP, Head, Global Patient Safety Evaluation (Takeda) and Abimbola Cole, Post-PharmD Fellow (Takeda)
Takeda Boston – Register Now! For more information and registration, please click here

Teratology Education Course and 3rd Joint International ENTIS / OTIS meeting

4-6 September 2018
Newcastle upon Tyne, United Kingdom
Don’t miss this unique opportunity to hear state-of-the-art lectures from UK and international experts on :
·        Fetal development
·        Principles of human teratology
·        Known and emerging human teratogens of relevance today
·        Effects of maternal illness on pregnancy outcome
·        Risk-benefit analysis of medicine use in pregnancy and lactation
·        Pregnancy pharmacovigilance and clinical application of pregnancy safety data
·        Risk communication in the context of human teratogens
Register now! Full provisional programmes available on the conference website.